Vir Biotechnology - Stock Price History | VIR

Historical daily share price chart and data for Vir Biotechnology since 2021 adjusted for splits. The latest closing stock price for Vir Biotechnology as of October 15, 2021 is 39.09.
  • The all-time high Vir Biotechnology stock closing price was 83.07 on January 27, 2021.
  • The Vir Biotechnology 52-week high stock price is 141.01, which is 260.7% above the current share price.
  • The Vir Biotechnology 52-week low stock price is 25.31, which is 35.3% below the current share price.
  • The average Vir Biotechnology stock price for the last 52 weeks is 43.58.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Vir Biotechnology Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 34.0578 12.1500 60.2000 12.0400 26.7800 112.96%
2019 13.3965 14.0200 15.8500 11.8300 12.5750 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.106B $0.076B
Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The company's development pipeline consists of product candidates targeting the hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis. Vir Biotechnology Inc. is based in San Francisco, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00